Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027

Cash on hand will fund the planned repayment of the subsidiary's 8.500% Senior Notes due 2027.

Rhea-AI Summary

Bausch Health (BHC) announced that its subsidiary Bausch Health Americas will redeem approximately $643 million in outstanding notes.

The full redemption covers the subsidiary's 8.500% Senior Notes due 2027 and is scheduled for November 30, 2026, using cash on hand. Bausch Health Americas will issue an irrevocable redemption notice dated October 29, 2026, to record holders. The indenture governing the notes will be terminated in connection with the redemption. Payment and surrender of the notes will take place through the Depository Trust Company's procedures.

1 point · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.Approximately $643 million in outstanding 8.500% Senior Notes due 2027 will be fully redeemed November 30, 2026. 27% of market cap

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.Cash on hand will fund the redemption of approximately $643 million in note principal. 27% of market cap

Argus 15 min delay 82 alerts

+13.50% vs previous close $7.85 last price 4.3x rel. volume Open Argus

Details

Market Reaction – BHC

+2.5% Peak in 5 min

$6.21 – $8.52 Day Range

$2.94B Mkt Cap at Last Price

On Oct 28, the day this news came out, the latest delayed price for BHC is 13.50% above the previous close. Argus tracked a peak move of +2.5% during the session. Our momentum scanner has recorded 82 alerts for this stock so far that day. The latest delayed price is $7.85. Relative volume is very high at 4.3x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Aggregate principal to be redeemed: $643 million Note interest rate: 8.500% Redemption date: November 30, 2026

Aggregate principal to be redeemed

$643 million

Approximate amount of outstanding 8.500% Senior Notes; redemption funded with cash on hand

Note interest rate

8.500%

Senior Notes due 2027

Redemption date

November 30, 2026

Scheduled redemption of the Notes

Key Terms

senior notes, cusip, indenture

3 terms

senior notes financial

"redeem approximately $643 million of aggregate principal amount of its outstanding 8.500% Senior Notes"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

cusip financial

"CUSIP Nos. 91911XAW4 and U9098VAP7"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

View in glossary

indenture financial

"the indenture pursuant to which the Notes were issued will be terminated"

An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its subsidiary, Bausch Health Americas, Inc., will issue an irrevocable notice of redemption dated as of October 29, 2026 pursuant to which it will redeem approximately $643 million of aggregate principal amount of its outstanding 8.500% Senior Notes due 2027, CUSIP Nos. 91911XAW4 and U9098VAP7 (the "Notes"), using cash on hand. The redemption date is November 30, 2026. The notice of redemption will be issued to the record holders of such Notes. Nothing contained herein shall constitute a notice of redemption of the Notes. Payment of the redemption price and surrender of the Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. The name and address of the U.S. paying agent are as follows: The Bank of New York Mellon, 240 Greenwich Street, Floor 7E, New York, New York 10286; Attn: Corporate Trust Administration. In connection with the redemption, the indenture pursuant to which the Notes were issued will be terminated.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:	Media Contact:
Garen Sarafian	Alexis Navratil
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll free)	(848) 264-0934
BHC-FINANCIAL

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-full-redemption-of-8-500-senior-notes-due-2027--302922569.html

SOURCE Bausch Health Companies Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bausch Health redeem its 8.500% Senior Notes due 2027?

Bausch Health Americas will redeem the notes on November 30, 2026. The full redemption covers approximately $643 million in aggregate principal and will be funded with cash on hand.